TSH Biopharm (ROCO:8432) E10: NT$2.55 (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ROCO:8432 TSH Biopharm Corp Ltd ROCO:8432
84 GF Score
Price NT$50.20
GF Value NT$78.92
Valuation Significantly Undervalued
! 1 Warning Sign
View Full Analysis

What is TSH Biopharm E10?

TSH Biopharm ROCO:8432 84 E10 is NT$2.55 as of Dec. 2025. GuruFocus rates ROCO:8432 with a GF Score™ of 84/100 and a GF Value™ of NT$78.92 (Significantly Undervalued). The stock has 1 warning sign investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

TSH Biopharm's adjusted earnings per share data for the three months ended in Dec. 2025 was NT$0.620. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is NT$2.55 for the trailing ten years ended in Dec. 2025.

During the past 12 months, TSH Biopharm's average E10 Growth Rate was 5.40% per year. During the past 3 years, the average E10 Growth Rate was 1.20% per year. During the past 5 years, the average E10 Growth Rate was -2.90% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of TSH Biopharm was 1.20% per year. The lowest was -7.50% per year. And the median was -3.00% per year.

As of today (2026-07-15), TSH Biopharm's current stock price is NT$50.20. TSH Biopharm's E10 for the quarter that ended in Dec. 2025 was NT$2.55. TSH Biopharm's Shiller PE Ratio of today is 19.69.

During the past 13 years, the highest Shiller PE Ratio of TSH Biopharm was 29.41. The lowest was 14.22. And the median was 19.88.


TSH Biopharm  (ROCO:8432) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

TSH Biopharm's Shiller P/E Ratio of today is calculated as

Shiller PE Ratio=Share Price/E10
=50.20/2.55
=19.69

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Shiller P/E Ratio of TSH Biopharm was 29.41. The lowest was 14.22. And the median was 19.88.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


TSH Biopharm E10 Related Terms


TSH Biopharm E10 Historical Data

* Premium members only.

The historical data trend for TSH Biopharm's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

TSH Biopharm E10 Chart

TSH Biopharm Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.65 2.46 2.32 2.42 2.55

TSH Biopharm Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.42 2.49 2.49 2.61 2.55

ROCO:8432 vs ZTS, UTHR: E10 Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, TSH Biopharm's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


TSH Biopharm Shiller PE Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, TSH Biopharm's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where TSH Biopharm's Shiller PE Ratio falls into.


ROCO:8432
84GF Score
TSH Biopharm Corp Ltd ROCO:8432
E10 is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

TSH Biopharm E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, TSH Biopharm's adjusted earnings per share data for the three months ended in Dec. 2025 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Dec. 2025 (Change)*Current CPI (Dec. 2025)
=0.62/324.0540*324.0540
=0.620

Current CPI (Dec. 2025) = 324.0540.

TSH Biopharm Quarterly Data

per share eps CPI Adj_EPS
201603 1.460 238.132 1.987
201606 1.940 241.018 2.608
201609 0.060 241.428 0.081
201612 0.200 241.432 0.268
201703 0.330 243.801 0.439
201706 0.490 244.955 0.648
201709 0.480 246.819 0.630
201712 0.390 246.524 0.513
201803 0.860 249.554 1.117
201806 0.160 251.989 0.206
201809 0.240 252.439 0.308
201812 0.240 251.233 0.310
201903 0.660 254.202 0.841
201906 0.220 256.143 0.278
201909 1.200 256.759 1.515
201912 0.140 256.974 0.177
202003 0.620 258.115 0.778
202006 0.210 257.797 0.264
202009 0.400 260.280 0.498
202012 0.370 260.474 0.460
202103 0.250 264.877 0.306
202106 0.340 271.696 0.406
202109 0.260 274.310 0.307
202112 0.380 278.802 0.442
202203 0.510 287.504 0.575
202206 0.420 296.311 0.459
202209 0.470 296.808 0.513
202212 0.210 296.797 0.229
202303 0.280 301.836 0.301
202306 0.480 305.109 0.510
202309 0.440 307.789 0.463
202312 0.420 306.746 0.444
202403 1.060 312.332 1.100
202406 0.360 314.175 0.371
202409 1.260 315.301 1.295
202412 0.250 315.605 0.257
202503 0.790 319.799 0.801
202506 0.680 322.561 0.683
202509 1.530 324.800 1.526
202512 0.620 324.054 0.620

Add all the adjusted EPS together and divide 10 will get our e10.

Frequently Asked Questions Learn more about E10 →
What does a E10 of NT$2.55 mean?
TSH Biopharm (ROCO:8432) has a E10 of NT$2.55 as of Dec. 2025. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on TSH Biopharm and its competitors.
Is TSH Biopharm's E10 too high?
TSH Biopharm's current E10 is NT$2.55. Overall, TSH Biopharm has a GF Score™ of 84/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does TSH Biopharm's E10 compare to ZTS and UTHR?
TSH Biopharm's E10 of NT$2.55 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good E10 for a Drug Manufacturers company?
A good E10 depends on the Drug Manufacturers industry context. However, E10 should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high E10 mean?
A high E10 can signal that a stock is expensive relative to its fundamentals. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on TSH Biopharm and its competitors. TSH Biopharm's current E10 is NT$2.55. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is TSH Biopharm stock overvalued right now?
Based on GuruFocus' analysis, TSH Biopharm (ROCO:8432) is currently considered Significantly Undervalued. The stock's GF Value™ is NT$78.92, compared to a current price of NT$50.20 — trading 36.4% below its estimated fair value. The current E10 is NT$2.55. TSH Biopharm's overall GF Score™ is 84/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is E10 calculated?
E10 is calculated from a company's financial statements. For TSH Biopharm (ROCO:8432), the current E10 is NT$2.55 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is TSH Biopharm (ROCO:8432) Overvalued in 2026?

Based on GuruFocus' analysis, TSH Biopharm stock appears to be undervalued. The current stock price of NT$50.20 is trading 36.4% below its estimated GF Value™ of NT$78.92. GuruFocus considers TSH Biopharm to be Significantly Undervalued.

Key valuation signals for ROCO:8432:

  • E10: NT$2.55
  • GF Value™: NT$78.92 vs. price of NT$50.20 (36.4% below fair value)
  • GF Score™: 84/100 with 1 warning sign

No single metric tells the full story. See the ROCO:8432 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


TSH Biopharm Business Description

Address No.3-1, Park Street, 3rd Floor-1, Nangang District, Taipei, TWN, 115
TSH Biopharm Corp Ltd is engaged in sale of a variety of pharmaceuticals, chemical drugs and engaged in biotechnology services. The company specializes in the development, manufacture, and marketing of branded drugs for chronic diseases. Key therapeutic areas include cardiovascular, central nervous system, gastroenterology, and severe chronic diseases, alongside precision medicine/genetic testing services .The Company's revenue is earned domestically. It earns majority of its revenue from the sale of Lozenges.
84GF Score

Get the complete analysis for ROCO:8432

E10 is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$50.20
Price
NT$78.92
GF Value